University Chicago Hospital StudyCoordinator:CEPO906A2229 — Chicago, Illinois

University Chicago Hospital StudyCoordinator:CEPO906A2229 is a clinical research site located in Chicago, Illinois, United States 60637.

Crixeo Clinical Trials Trust Score: 88/100 (GOOD). This profile has not yet been claimed by the site owner.

University Chicago Hospital StudyCoordinator:CEPO906A2229 has participated in 1 clinical trials.

Therapeutic areas: Metastatic Hormone Refractory Prostate Cancer.

Sponsors: Novartis Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Chicago

Browse all research sites in Illinois · View every site in Chicago

Sponsor Feasibility Report

Trust Score: 88/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University Chicago Hospital StudyCoordinator:CEPO906A2229?

University Chicago Hospital StudyCoordinator:CEPO906A2229 has a Crixeo Trust Score of 88/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University Chicago Hospital StudyCoordinator:CEPO906A2229 conducted?

University Chicago Hospital StudyCoordinator:CEPO906A2229 has 1 clinical trials on record. Their work covers Metastatic Hormone Refractory Prostate Cancer.

Is University Chicago Hospital StudyCoordinator:CEPO906A2229 accredited by Crixeo Clinical Trials?

University Chicago Hospital StudyCoordinator:CEPO906A2229 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University Chicago Hospital StudyCoordinator:CEPO906A2229?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.